Recent Comments

Comment RSS

Venlafaxine News and Research RSS Feed - Venlafaxine News and Research

Venlafaxine is an antidepressant drug that is being evaluated for the treatment of hot flashes in women who have breast cancer.

Antidepressant market to decline: Datamonitor

28. October 2009 06:06
Research and Markets (http://www.researchandmarkets.com/research/881581/commercial_insight) has announced the addition of the "Commercial Insight: Antidepressants - Novel Mechanism Offers Hope in Depressed Market" report to their offering. [More]

Posted in: Pharmaceutical News

Tags: , , , , , ,

Results from the BRITE-MD trials published in Psychiatry Research: Aspect Medical Systems

11. September 2009 08:23
Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that two companion articles highlighting results from the BRITE-MD (Biomarkers for Rapid Identification of Treatment Effectiveness trial in Major Depression) were published in the September issue of the journal Psychiatry Research. [More]

Merck update on the status of telcagepant clinical development programs

11. September 2009 05:38
Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine. [More]

Venlafaxine alleviates depressive symptoms

25. August 2009 23:36
The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to investigate whether patients with depression benefit from taking drugs belonging to the selective serotonin and norepinephrine reuptake inhibitor (SNRI) drug class. [More]

Antidepressants aid electroconvulsive therapy in treating severe depression

6. July 2009 19:25
Combining antidepressant drugs with electroconvulsive therapy (ECT) does a better job of reducing symptoms of severe depression and causes less memory loss than using ECT alone, according to a new study by researchers at Wake Forest University School of Medicine and colleagues. [More]

Posted in: Drug Trial News

Tags: , , , , ,

Major depression, antidepressant medication and the risk of obesity

23. June 2009 04:40
Cross-sectional studies have reported an association between major depressive episode (MDE) and obesity. The objective of this longitudinal analysis was to determine whether MDE increase the risk of becoming obese over a 10-year period. [More]

Aussies wanted for international groundbreaking study on depression

26. April 2009 19:27
Australians researchers have put out a call for 400 people to take part in a study on depression. [More]

Groundbreaking study into depression

19. March 2009 18:26
Medical researchers from Sydney University's Brain Dynamics Centre have launched a world-first study that could lead to a dramatic improvement in how people are treated medically for depression. [More]

Posted in: Medical Condition News

Tags: , ,

Expectant brains help predict anxiety treatment success

5. January 2009 03:47
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment. [More]

Untapped potential of antidepressants for cancer

11. September 2008 19:47
A comprehensive review of current scientific literature, published in the peer-reviewed journal ecancer, has suggested that antidepressants can help the human body fight cancer by boosting its own immune response, amongst other mechanisms. [More]

Scientists predict new uses for existing drugs from their side effects

10. July 2008 17:52
Researchers from the European Molecular Biology Laboratory (EMBL) discovered a new way to make use of drugs' unwanted side effects. They developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule. The study, published in Science this week, hints at new uses of marketed drugs. [More]

Posted in: Drug Trial News

Tags: , , , , ,

Mylan announces FDA approval for generic Effexor and tentative approval for generic antihypertensive Avalide

16. June 2008 16:55
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base). [More]

Posted in: Pharmaceutical News

Tags: , , ,

When your antidepressants don't work

26. March 2008 07:01
should you switch to a different medication from the same class or should you try an antidepressant medication that has a different mechanism of action? [More]

FDA approves PRISTIQ for the treatment of adult patients with major depressive disorder

3. March 2008 14:32
Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) has approved PRISTIQ (desvenlafaxine), a structurally novel, once-daily serotonin-norepinephrine reuptake inhibitor (SNRI), to treat adult patients with major depressive disorder (MDD). [More]

Antidepressants only benefit some

27. February 2008 22:01
A new study published today in PLoS Medicine suggests that antidepressants only benefit some, very severely depressed patients. [More]

Posted in: Drug Trial News

Tags: , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.